{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:28:21Z","timestamp":1774459701339,"version":"3.50.1"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Abu Dhabi Department of Education and Knowledge (ADEK) through the Abu Dhabi Award for Research Excellence","award":["21M136"],"award-info":[{"award-number":["21M136"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>With the emergence of the novel coronavirus SARS-CoV-2 since December 2019, more than 65 million cases have been reported worldwide. This virus has shown high infectivity and severe symptoms in some cases, leading to over 1.5 million deaths globally. Despite the collaborative and concerted research efforts that have been made, no effective medication for COVID-19 (coronavirus disease-2019) is currently available. SARS-CoV-2 uses the angiotensin-converting enzyme 2 (ACE2) as an initial mediator for viral attachment and host cell invasion. ACE2 is widely distributed in the human tissues including the cell surface of lung cells which represent the primary site of the infection. Inhibiting or reducing cell surface availability of ACE2 represents a promising therapy for tackling COVID-19. In this context, most ACE2\u2013based therapeutic strategies have aimed to tackle the virus through the use of angiotensin-converting enzyme (ACE) inhibitors or neutralizing the virus by exogenous administration of ACE2, which does not directly aim to reduce its membrane availability. However, through this review, we present a different perspective focusing on the subcellular localization and trafficking of ACE2. Membrane targeting of ACE2, and shedding and cellular trafficking pathways including the internalization are not well elucidated in literature. Therefore, we hereby present an overview of the fate of newly synthesized ACE2, its post translational modifications, and what is known of its trafficking pathways. In addition, we highlight the possibility that some of the identified ACE2 missense variants might affect its trafficking efficiency and localization and hence may explain some of the observed variable severity of SARS-CoV-2 infections. Moreover, an extensive understanding of these processes is necessarily required to evaluate the potential use of ACE2 as a credible therapeutic target.<\/jats:p>","DOI":"10.1186\/s40246-021-00304-9","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T04:42:23Z","timestamp":1611895343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues"],"prefix":"10.1186","volume":"15","author":[{"given":"Sally","family":"Badawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1306-6618","authenticated-orcid":false,"given":"Bassam R.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"key":"304_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1748-1716.1898.tb00272.x","volume":"8","author":"R Tigerstedt","year":"1898","unstructured":"Tigerstedt R, Bergman PQ. Niere und Kreislauf1. Skand Arch F\u00fcr Physiol. 1898;8:223\u201371. https:\/\/doi.org\/10.1111\/j.1748-1716.1898.tb00272.x.","journal-title":"Skand Arch F\u00fcr Physiol"},{"key":"304_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1084\/jem.103.3.295","volume":"103","author":"LT Skeggs","year":"1956","unstructured":"Skeggs LT, Kahn JR, Shumway NP. The preparation and function of the hypertensin-converting enzyme. J Exp Med. 1956;103:295\u20139 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2136590\/. Accessed 24 Oct 2020.","journal-title":"J Exp Med"},{"key":"304_CR3","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","volume":"87","author":"M Donoghue","year":"2000","unstructured":"Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000;87:E1\u20139.","journal-title":"Circ Res."},{"key":"304_CR4","doi-asserted-by":"publisher","first-page":"33238","DOI":"10.1074\/jbc.M002615200","volume":"275","author":"SR Tipnis","year":"2000","unstructured":"Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem. 2000;275:33238\u201343.","journal-title":"J Biol Chem"},{"key":"304_CR5","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nature00786","volume":"417","author":"MA Crackower","year":"2002","unstructured":"Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002;417:822\u20138. https:\/\/doi.org\/10.1038\/nature00786.","journal-title":"Nature."},{"key":"304_CR6","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","volume":"5","author":"M Letko","year":"2020","unstructured":"Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020;5:562\u20139. https:\/\/doi.org\/10.1038\/s41564-020-0688-y.","journal-title":"Nat Microbiol."},{"key":"304_CR7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270\u20133. https:\/\/doi.org\/10.1038\/s41586-020-2012-7.","journal-title":"Nature."},{"key":"304_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-00426-x","volume":"5","author":"K Wang","year":"2020","unstructured":"Wang K, Chen W, Zhang Z, Deng Y, Lian J-Q, Du P, et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther. 2020;5:1\u201310. https:\/\/doi.org\/10.1038\/s41392-020-00426-x.","journal-title":"Signal Transduct Target Ther"},{"key":"304_CR9","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s12015-020-09976-7","volume":"16","author":"H Ulrich","year":"2020","unstructured":"Ulrich H, Pillat MM. CD147 as a target for COVID-19 treatment: suggested effects of azithromycin and stem cell engagement. Stem Cell Rev Rep. 2020;16:434\u201340.","journal-title":"Stem Cell Rev Rep."},{"key":"304_CR10","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1126\/science.abd3072","volume":"370","author":"JL Daly","year":"2020","unstructured":"Daly JL, Simonetti B, Klein K, Chen K-E, Williamson MK, Ant\u00f3n-Pl\u00e1garo C, et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science. 2020;370:861\u20135. https:\/\/doi.org\/10.1126\/science.abd3072.","journal-title":"Science."},{"key":"304_CR11","doi-asserted-by":"publisher","first-page":"101160","DOI":"10.1016\/j.isci.2020.101160","volume":"23","author":"Y Li","year":"2020","unstructured":"Li Y, Zhang Z, Yang L, Lian X, Xie Y, Li S, et al. The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike. iScience. 2020;23:101160. https:\/\/doi.org\/10.1016\/j.isci.2020.101160.","journal-title":"iScience"},{"key":"304_CR12","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","volume":"9","author":"N Vankadari","year":"2020","unstructured":"Vankadari N, Wilce JA. Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microbes Infect. 2020;9:601\u20134. https:\/\/doi.org\/10.1080\/22221751.2020.1739565.","journal-title":"Emerg Microbes Infect."},{"key":"304_CR13","doi-asserted-by":"publisher","unstructured":"Cui C, Huang C, Zhou W, Ji X, Zhang F, Wang L, Zhou Y, Cui Q. AGTR2, one possible novel key gene for the entry of SARS-CoV-2 into human cells. IEEE\/ACM Trans Comput Biol Bioinform. 2020.\u00a0https:\/\/doi.org\/10.1109\/TCBB.2020.3009099.","DOI":"10.1109\/TCBB.2020.3009099"},{"key":"304_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbrc.2020.03.044","volume":"526","author":"F Qi","year":"2020","unstructured":"Qi F, Qian S, Zhang S, Zhang Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun. 2020;526:135\u201340.","journal-title":"Biochem Biophys Res Commun."},{"key":"304_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1161\/HYPERTENSIONAHA.109.138420","volume":"55","author":"J Wysocki","year":"2010","unstructured":"Wysocki J, Ye M, Rodriguez E, Gonz\u00e1lez-Pacheco FR, Barrios C, Evora K, et al. Targeting the degradation of angiotensin II with recombinant ACE2: prevention of angiotensin II-dependent hypertension. Hypertension. 2010;55:90\u20138. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.138420.","journal-title":"Hypertension"},{"key":"304_CR16","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s40262-013-0072-7","volume":"52","author":"M Haschke","year":"2013","unstructured":"Haschke M, Schuster M, Poglitsch M, Loibner H, Salzberg M, Bruggisser M, et al. Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects. Clin Pharmacokinet. 2013;52:783\u201392.","journal-title":"Clin Pharmacokinet."},{"key":"304_CR17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13054-017-1823-x","volume":"21","author":"A Khan","year":"2017","unstructured":"Khan A, Benthin C, Zeno B, Albertson TE, Boyd J, Christie JD, et al. A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Crit Care. 2017;21:234. https:\/\/doi.org\/10.1186\/s13054-017-1823-x.","journal-title":"Crit Care."},{"key":"304_CR18","unstructured":"LI Y. A Randomized, Open Label, Controlled clinical study to evaluate the recombinant human angiotensin-converting enzyme 2 (rhACE2) in adult patients with COVID-19. Clinical trial registration.clinicaltrials.gov; 2020. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04287686. Accessed 6 Dec 2020."},{"key":"304_CR19","doi-asserted-by":"publisher","unstructured":"Masters PS. The molecular biology of coronaviruses. In: Advances in Virus Research: Academic Press; 2006. p. 193\u2013292. https:\/\/doi.org\/10.1016\/S0065-3527(06)66005-3.","DOI":"10.1016\/S0065-3527(06)66005-3"},{"key":"304_CR20","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1126\/science.1118391","volume":"310","author":"W Li","year":"2005","unstructured":"Li W, Shi Z, Yu M, Ren W, Smith C, Epstein JH, et al. Bats are natural reservoirs of SARS-like coronaviruses. Science. 2005;310:676\u20139.","journal-title":"Science."},{"key":"304_CR21","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.3201\/eid1910.130946","volume":"19","author":"NL Ithete","year":"2013","unstructured":"Ithete NL, Stoffberg S, Corman VM, Cottontail VM, Richards LR, Schoeman MC, et al. Close relative of human middle east respiratory syndrome coronavirus in bat. South Africa. Emerg Infect Dis. 2013;19:1697\u20139. https:\/\/doi.org\/10.3201\/eid1910.130946.","journal-title":"South Africa. Emerg Infect Dis"},{"key":"304_CR22","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.3201\/eid1112.041293","volume":"11","author":"M Wang","year":"2005","unstructured":"Wang M, Yan M, Xu H, Liang W, Kan B, Zheng B, et al. SARS-CoV infection in a restaurant from palm civet. Emerg Infect Dis. 2005;11:1860\u20135. https:\/\/doi.org\/10.3201\/eid1112.041293.","journal-title":"Emerg Infect Dis."},{"key":"304_CR23","first-page":"1231","volume":"20","author":"MG Hemida","year":"2014","unstructured":"Hemida MG, Chu DKW, Poon LLM, Perera RAPM, Alhammadi MA, Ng H-Y, et al. MERS coronavirus in dromedary camel herd. Saudi Arabia. Emerg Infect Dis. 2014;20:1231\u20134.","journal-title":"Saudi Arabia. Emerg Infect Dis"},{"key":"304_CR24","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s42770-020-00321-1","volume":"51","author":"LR Lopes","year":"2020","unstructured":"Lopes LR, de Mattos CG, Paiva PB. Molecular evolution and phylogenetic analysis of SARS-CoV-2 and hosts ACE2 protein suggest Malayan pangolin as intermediary host. Braz J Microbiol. 2020;51:1593\u20139. https:\/\/doi.org\/10.1007\/s42770-020-00321-1.","journal-title":"Braz J Microbiol"},{"key":"304_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.24272\/j.issn.2095-8137.2020.031","volume":"41","author":"G Wong","year":"2020","unstructured":"Wong G, Bi Y-H, Wang Q-H, Chen X-W, Zhang Z-G, Yao Y-G. Zoonotic origins of human coronavirus 2019 (HCoV-19\/SARS-CoV-2): why is this work important? Zool Res. 2020;41:213\u20139. https:\/\/doi.org\/10.24272\/j.issn.2095-8137.2020.031.","journal-title":"Zool Res"},{"key":"304_CR26","doi-asserted-by":"publisher","first-page":"101384","DOI":"10.1016\/j.isci.2020.101384","volume":"23","author":"M Braun","year":"2020","unstructured":"Braun M, Sharon E, Unterman I, Miller M, Shtern AM, Benenson S, et al. ACE2 co-evolutionary pattern suggests targets for pharmaceutical intervention in the COVID-19 pandemic. iScience. 2020;23:101384. https:\/\/doi.org\/10.1016\/j.isci.2020.101384.","journal-title":"iScience"},{"key":"304_CR27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jinf.2020.02.013","volume":"80","author":"R Li","year":"2020","unstructured":"Li R, Qiao S, Zhang G. Analysis of angiotensin-converting enzyme 2 (ACE2) from different species sheds some light on cross-species receptor usage of a novel coronavirus 2019-nCoV. J Infect. 2020;80:469\u201396. https:\/\/doi.org\/10.1016\/j.jinf.2020.02.013.","journal-title":"J Infect."},{"key":"304_CR28","doi-asserted-by":"publisher","unstructured":"Wells HL, Letko M, Lasso G, Ssebide B, Nziza J, Byarugaba DK, et al. The evolutionary history of ACE2 usage within the coronavirus subgenus Sarbecovirus. bioRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.07.07.190546.","DOI":"10.1101\/2020.07.07.190546"},{"key":"304_CR29","doi-asserted-by":"publisher","first-page":"eabb9153","DOI":"10.1126\/sciadv.abb9153","volume":"6","author":"X Li","year":"2020","unstructured":"Li X, Giorgi EE, Marichannegowda MH, Foley B, Xiao C, Kong X-P, et al. Emergence of SARS-CoV-2 through recombination and strong purifying selection. Sci Adv. 2020;6:eabb9153. https:\/\/doi.org\/10.1126\/sciadv.abb9153.","journal-title":"Sci Adv"},{"key":"304_CR30","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1038\/s41366-020-00689-y","volume":"44","author":"K Schlicht","year":"2020","unstructured":"Schlicht K, Rohmann N, Geisler C, Hollstein T, Knappe C, Hartmann K, et al. Circulating levels of soluble dipeptidylpeptidase-4 are reduced in human subjects hospitalized for severe COVID-19 infections. Int J Obes. 2020;44:2335\u20138. https:\/\/doi.org\/10.1038\/s41366-020-00689-y.","journal-title":"Int J Obes."},{"key":"304_CR31","doi-asserted-by":"publisher","unstructured":"Cui J, Eden J-S, Holmes EC, Wang L-F. Adaptive evolution of bat dipeptidyl peptidase 4 (dpp4): implications for the origin and emergence of Middle East respiratory syndrome coronavirus. Virol J. 2013;10. https:\/\/doi.org\/10.1186\/1743-422X-10-304.","DOI":"10.1186\/1743-422X-10-304"},{"key":"304_CR32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1042\/bj2230255","volume":"223","author":"E Sch\u00f6n","year":"1984","unstructured":"Sch\u00f6n E, Demuth HU, Barth A, Ansorge S. Dipeptidyl peptidase IV of human lymphocytes. Evidence for specific hydrolysis of glycylproline p-nitroanilide in T-lymphocytes. Biochem J. 1984;223:255\u20138. https:\/\/doi.org\/10.1042\/bj2230255.","journal-title":"Biochem J."},{"key":"304_CR33","doi-asserted-by":"publisher","first-page":"110186","DOI":"10.1016\/j.mehy.2020.110186","volume":"144","author":"P Phyu Khin","year":"2020","unstructured":"Phyu Khin P, Cha S-H, Jun H-S, Lee JH. A potential therapeutic combination for treatment of COVID-19: synergistic effect of DPP4 and RAAS suppression. Med Hypotheses. 2020;144:110186. https:\/\/doi.org\/10.1016\/j.mehy.2020.110186.","journal-title":"Med Hypotheses."},{"key":"304_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e05143","volume":"6","author":"F Amati","year":"2020","unstructured":"Amati F, Vancheri C, Latini A, Colona VL, Grelli S, D\u2019Apice MR, et al. Expression profiles of the SARS-CoV-2 host invasion genes in nasopharyngeal and oropharyngeal swabs of COVID-19 patients. Heliyon. 2020;6:e05143. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e05143.","journal-title":"Heliyon"},{"key":"304_CR35","doi-asserted-by":"publisher","first-page":"13185","DOI":"10.1021\/bi035268s","volume":"42","author":"JL Guy","year":"2003","unstructured":"Guy JL, Jackson RM, Acharya KR, Sturrock ED, Hooper NM, Turner AJ. Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence. Biochemistry. 2003;42:13185\u201392.","journal-title":"Biochemistry."},{"key":"304_CR36","doi-asserted-by":"publisher","first-page":"17996","DOI":"10.1074\/jbc.M311191200","volume":"279","author":"P Towler","year":"2004","unstructured":"Towler P, Staker B, Prasad SG, Menon S, Tang J, Parsons T, et al. ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J Biol Chem. 2004;279:17996\u20138007.","journal-title":"J Biol Chem."},{"key":"304_CR37","doi-asserted-by":"publisher","first-page":"17132","DOI":"10.1074\/jbc.M006723200","volume":"276","author":"H Zhang","year":"2001","unstructured":"Zhang H, Wada J, Hida K, Tsuchiyama Y, Hiragushi K, Shikata K, et al. Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys. J Biol Chem. 2001;276:17132\u20139. https:\/\/doi.org\/10.1074\/jbc.M006723200.","journal-title":"J Biol Chem."},{"key":"304_CR38","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/nature05475","volume":"444","author":"U Danilczyk","year":"2006","unstructured":"Danilczyk U, Sarao R, Remy C, Benabbas C, Stange G, Richter A, et al. Essential role for collectrin in renal amino acid transport. Nature. 2006;444:1088\u201391. https:\/\/doi.org\/10.1038\/nature05475.","journal-title":"Nature."},{"key":"304_CR39","doi-asserted-by":"publisher","first-page":"F533","DOI":"10.1152\/ajprenal.00325.2006","volume":"292","author":"SM Malakauskas","year":"2007","unstructured":"Malakauskas SM, Quan H, Fields TA, McCall SJ, Yu M-J, Kourany WM, et al. Aminoaciduria and altered renal expression of luminal amino acid transporters in mice lacking novel gene collectrin. Am J Physiol Renal Physiol. 2007;292:F533\u201344.","journal-title":"Am J Physiol Renal Physiol"},{"key":"304_CR40","first-page":"2880","volume":"22","author":"S Kowalczuk","year":"2008","unstructured":"Kowalczuk S, Br\u00f6er A, Tietze N, Vanslambrouck JM, Rasko JEJ, Br\u00f6er S. A protein complex in the brush-border membrane explains a Hartnup disorder allele. FASEB J Off Publ Fed Am Soc Exp Biol. 2008;22:2880\u20137.","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"304_CR41","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1053\/j.gastro.2008.10.055","volume":"136","author":"SMR Camargo","year":"2009","unstructured":"Camargo SMR, Singer D, Makrides V, Huggel K, Pos KM, Wagner CA, et al. Tissue-specific amino acid transporter partners ACE2 and collectrin differentially interact with hartnup mutations. Gastroenterology. 2009;136:872\u201382.","journal-title":"Gastroenterology"},{"key":"304_CR42","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367:1444\u20138. https:\/\/doi.org\/10.1126\/science.abb2762.","journal-title":"Science."},{"key":"304_CR43","doi-asserted-by":"publisher","first-page":"L84","DOI":"10.1152\/ajplung.00071.2009","volume":"297","author":"HP Jia","year":"2009","unstructured":"Jia HP, Look DC, Tan P, Shi L, Hickey M, Gakhar L, et al. Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia. Am J Physiol Lung Cell Mol Physiol. 2009;297:L84\u201396.","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"304_CR44","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/s41588-020-00731-9","volume":"52","author":"OO Onabajo","year":"2020","unstructured":"Onabajo OO, Banday AR, Stanifer ML, Yan W, Obajemu A, Santer DM, et al. Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor. Nat Genet. 2020;52:1283\u201393. https:\/\/doi.org\/10.1038\/s41588-020-00731-9.","journal-title":"Nat Genet."},{"key":"304_CR45","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/s41588-020-00732-8","volume":"52","author":"KW Ng","year":"2020","unstructured":"Ng KW, Attig J, Bolland W, Young GR, Major J, Wrobel AG, et al. Tissue-specific and interferon-inducible expression of nonfunctional ACE2 through endogenous retroelement co-option. Nat Genet. 2020;52:1294\u2013302. https:\/\/doi.org\/10.1038\/s41588-020-00732-8.","journal-title":"Nat Genet."},{"key":"304_CR46","doi-asserted-by":"publisher","first-page":"39353","DOI":"10.1074\/jbc.M508914200","volume":"280","author":"FJ Warner","year":"2005","unstructured":"Warner FJ, Lew RA, Smith AI, Lambert DW, Hooper NM, Turner AJ. Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells. J Biol Chem. 2005;280:39353\u201362. https:\/\/doi.org\/10.1074\/jbc.M508914200.","journal-title":"J Biol Chem."},{"key":"304_CR47","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/eurheartj\/ehi114","volume":"26","author":"LM Burrell","year":"2005","unstructured":"Burrell LM, Risvanis J, Kubota E, Dean RG, MacDonald PS, Lu S, et al. Myocardial infarction increases ACE2 expression in rat and humans. Eur Heart J. 2005;26:369\u201375 discussion 322-324.","journal-title":"Eur Heart J"},{"key":"304_CR48","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1113\/expphysiol.2007.040139","volume":"93","author":"JL Guy","year":"2008","unstructured":"Guy JL, Lambert DW, Turner AJ, Porter KE. Functional angiotensin-converting enzyme 2 is expressed in human cardiac myofibroblasts. Exp Physiol. 2008;93:579\u201388. https:\/\/doi.org\/10.1113\/expphysiol.2007.040139.","journal-title":"Exp Physiol."},{"key":"304_CR49","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0014-5793(02)03640-2","volume":"532","author":"D Harmer","year":"2002","unstructured":"Harmer D, Gilbert M, Borman R, Clark KL. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. 2002;532:107\u201310.","journal-title":"FEBS Lett."},{"key":"304_CR50","doi-asserted-by":"publisher","first-page":"e9610","DOI":"10.15252\/msb.20209610","volume":"16","author":"F Hikmet","year":"2020","unstructured":"Hikmet F, M\u00e9ar L, Edvinsson \u00c5, Micke P, Uhl\u00e9n M, Lindskog C. The protein expression profile of ACE2 in human tissues. Mol Syst Biol. 2020;16:e9610. https:\/\/doi.org\/10.15252\/msb.20209610.","journal-title":"Mol Syst Biol"},{"key":"304_CR51","doi-asserted-by":"publisher","unstructured":"Ortiz ME, Thurman A, Pezzulo AA, Leidinger MR, Klesney-Tait JA, Karp PH, et al. Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract. EBioMedicine. 2020;60. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102976.","DOI":"10.1016\/j.ebiom.2020.102976"},{"key":"304_CR52","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1164\/rccm.202001-0179LE","volume":"202","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2. Am J Respir Crit Care Med. 2020;202:756\u20139. https:\/\/doi.org\/10.1164\/rccm.202001-0179LE.","journal-title":"Am J Respir Crit Care Med."},{"key":"304_CR53","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203:631\u20137. https:\/\/doi.org\/10.1002\/path.1570.","journal-title":"J Pathol."},{"key":"304_CR54","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.2337\/db20-0669","volume":"69","author":"SRA Wijnant","year":"2020","unstructured":"Wijnant SRA, Jacobs M, Eeckhoutte HPV, Lapauw B, Joos GF, Bracke KR, et al. Expression of ACE2, the SARS-CoV-2 receptor, in lung tissue of patients with type 2 diabetes. Diabetes. 2020;69:2691\u20139. https:\/\/doi.org\/10.2337\/db20-0669.","journal-title":"Diabetes"},{"key":"304_CR55","doi-asserted-by":"publisher","first-page":"R373","DOI":"10.1152\/ajpregu.00292.2006","volume":"292","author":"MF Doobay","year":"2007","unstructured":"Doobay MF, Talman LS, Obr TD, Tian X, Davisson RL, Lazartigues E. Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol. 2007;292:R373\u201381.","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"304_CR56","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s12020-008-9110-x","volume":"34","author":"M-J Niu","year":"2008","unstructured":"Niu M-J, Yang J-K, Lin S-S, Ji X-J, Guo L-M. Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice. Endocrine. 2008;34:56\u201361.","journal-title":"Endocrine."},{"key":"304_CR57","doi-asserted-by":"publisher","first-page":"115041","DOI":"10.1016\/j.bone.2019.115041","volume":"128","author":"CM Queiroz-Junior","year":"2019","unstructured":"Queiroz-Junior CM, Santos ACPM, Galv\u00e3o I, Souto GR, Mesquita RA, S\u00e1 MA, et al. The angiotensin converting enzyme 2\/angiotensin-(1-7)\/Mas receptor axis as a key player in alveolar bone remodeling. Bone. 2019;128:115041.","journal-title":"Bone."},{"key":"304_CR58","first-page":"833","volume":"87","author":"J Li","year":"2007","unstructured":"Li J, Gao J, Xu Y, Zhou T, Jin Y, Lou J. Expression of severe acute respiratory syndrome coronavirus receptors, ACE2 and CD209L in different organ derived microvascular endothelial cells. Zhonghua Yi Xue Za Zhi. 2007;87:833\u20137.","journal-title":"Zhonghua Yi Xue Za Zhi."},{"key":"304_CR59","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41440-018-0166-6","volume":"42","author":"Y Luo","year":"2019","unstructured":"Luo Y, Liu C, Guan T, Li Y, Lai Y, Li F, et al. Association of ACE2 genetic polymorphisms with hypertension-related target organ damages in south Xinjiang. Hypertens Res Off J Jpn Soc Hypertens. 2019;42:681\u20139.","journal-title":"Hypertens Res Off J Jpn Soc Hypertens"},{"key":"304_CR60","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1471-2350-14-117","volume":"14","author":"L Malard","year":"2013","unstructured":"Malard L, Kakinami L, O\u2019Loughlin J, Roy-Gagnon M-H, Labbe A, Pilote L, et al. The association between the angiotensin-converting enzyme-2 gene and blood pressure in a cohort study of adolescents. BMC Med Genet. 2013;14:117. https:\/\/doi.org\/10.1186\/1471-2350-14-117.","journal-title":"BMC Med Genet."},{"key":"304_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221248","volume":"14","author":"DS Pinheiro","year":"2019","unstructured":"Pinheiro DS, Santos RS, Jardim PCBV, Silva EG, Reis AAS, Pedrino GR, et al. The combination of ACE I\/D and ACE2 G8790A polymorphisms revels susceptibility to hypertension: a genetic association study in Brazilian patients. PloS One. 2019;14:e0221248.","journal-title":"PloS One."},{"key":"304_CR62","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3109\/03014460.2013.837195","volume":"41","author":"M Patnaik","year":"2014","unstructured":"Patnaik M, Pati P, Swain SN, Mohapatra MK, Dwibedi B, Kar SK, et al. Association of angiotensin-converting enzyme and angiotensin-converting enzyme-2 gene polymorphisms with essential hypertension in the population of Odisha. India. Ann Hum Biol. 2014;41:145\u201352.","journal-title":"India. Ann Hum Biol"},{"key":"304_CR63","doi-asserted-by":"publisher","unstructured":"Srivastava A, Bandopadhyay A, Das D, Pandey RK, Singh V, Khanam N, et al. Genetic association of ACE2 rs2285666 polymorphism with COVID-19 spatial distribution in India. Front Genet. 2020;11. https:\/\/doi.org\/10.3389\/fgene.2020.564741.","DOI":"10.3389\/fgene.2020.564741"},{"key":"304_CR64","doi-asserted-by":"publisher","unstructured":"Hamet P, Pausova Z, Attaoua R, Hishmih C, Haloui M, Shin J, Paus T, Abrhamowicz M, Gaudet D, Santucci L, Kotchen TA, Cowley AW, Hussin J, Tremblay J. SARS-COV-2 RECEPTOR ACE2 GENE is associated with hypertension and SEVERity of COVID 19: interaction with sex, obesity and SMOKING. Am J Hypertens. 2021;hpaa223. https:\/\/doi.org\/10.1093\/ajh\/hpaa223.","DOI":"10.1093\/ajh\/hpaa223"},{"key":"304_CR65","doi-asserted-by":"publisher","unstructured":"Cao Y, Li L, Feng Z, Wan S, Huang P, Sun X, et al. Comparative genetic analysis of the novel coronavirus (2019-nCoV\/SARS-CoV-2) receptor ACE2 in different populations. Cell Discov. 2020;6. https:\/\/doi.org\/10.1038\/s41421-020-0147-1.","DOI":"10.1038\/s41421-020-0147-1"},{"key":"304_CR66","doi-asserted-by":"publisher","unstructured":"Stawiski EW, Diwanji D, Suryamohan K, Gupta R, Fellouse FA, Sathirapongsasuti JF, et al. Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility. bioRxiv. 2020;:2020.04.07.024752. https:\/\/doi.org\/10.1101\/2020.04.07.024752.","DOI":"10.1101\/2020.04.07.024752"},{"key":"304_CR67","doi-asserted-by":"publisher","unstructured":"Al-Mulla F, Mohammad A, Madhoun AA, Haddad D, Ali H, Eaaswarkhanth M, et al. A comprehensive germline variant and expression analyses of ACE2, TMPRSS2 and SARS-CoV-2 activator FURIN genes from the Middle East: combating SARS-CoV-2 with precision medicine. bioRxiv. 2020:2020.05.16.099176. https:\/\/doi.org\/10.1101\/2020.05.16.099176.","DOI":"10.1101\/2020.05.16.099176"},{"key":"304_CR68","doi-asserted-by":"publisher","unstructured":"Novelli A, Biancolella M, Borgiani P, Cocciadiferro D, Colona VL, D\u2019Apice MR, et al. Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients. Hum Genomics. 2020;14. https:\/\/doi.org\/10.1186\/s40246-020-00279-z.","DOI":"10.1186\/s40246-020-00279-z"},{"key":"304_CR69","doi-asserted-by":"publisher","first-page":"5679","DOI":"10.1038\/s41598-017-06033-1","volume":"7","author":"B Al-Mubarak","year":"2017","unstructured":"Al-Mubarak B, Abouelhoda M, Omar A, AlDhalaan H, Aldosari M, Nester M, et al. Whole exome sequencing reveals inherited and de novo variants in autism spectrum disorder: a trio study from Saudi families. Sci Rep. 2017;7:5679. https:\/\/doi.org\/10.1038\/s41598-017-06033-1.","journal-title":"Sci Rep."},{"key":"304_CR70","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1111\/cns.12860","volume":"24","author":"J Peng","year":"2018","unstructured":"Peng J, Wang Y, He F, Chen C, Wu L, Yang L, et al. Novel West syndrome candidate genes in a Chinese cohort. CNS Neurosci Ther. 2018;24:1196\u2013206. https:\/\/doi.org\/10.1111\/cns.12860.","journal-title":"CNS Neurosci Ther"},{"key":"304_CR71","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.lfs.2019.03.059","volume":"225","author":"Z Fan","year":"2019","unstructured":"Fan Z, Wu G, Yue M, Ye J, Chen Y, Xu B, et al. Hypertension and hypertensive left ventricular hypertrophy are associated with ACE2 genetic polymorphism. Life Sci. 2019;225:39\u201345.","journal-title":"Life Sci."},{"key":"304_CR72","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.2337\/dc10-0349","volume":"33","author":"J-K Yang","year":"2010","unstructured":"Yang J-K, Zhou J-B, Xin Z, Zhao L, Yu M, Feng J-P, et al. Interactions among related genes of renin-angiotensin system associated with type 2 diabetes. Diabetes Care. 2010;33:2271\u20133.","journal-title":"Diabetes Care."},{"key":"304_CR73","doi-asserted-by":"publisher","first-page":"e12917","DOI":"10.1097\/MD.0000000000012917","volume":"97","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Cong M, Wang N, Li X, Zhang H, Zhang K, et al. Association of angiotensin-converting enzyme 2 gene polymorphism and enzymatic activity with essential hypertension in different gender: a case-control study. Medicine (Baltimore). 2018;97:e12917.","journal-title":"Medicine (Baltimore)"},{"key":"304_CR74","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12944-018-0890-6","volume":"17","author":"Y Pan","year":"2018","unstructured":"Pan Y, Wang T, Li Y, Guan T, Lai Y, Shen Y, et al. Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China. Lipids Health Dis. 2018;17:241.","journal-title":"Lipids Health Dis"},{"key":"304_CR75","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12933-018-0771-3","volume":"17","author":"C Liu","year":"2018","unstructured":"Liu C, Li Y, Guan T, Lai Y, Shen Y, Zeyaweiding A, et al. ACE2 polymorphisms associated with cardiovascular risk in Uygurs with type 2 diabetes mellitus. Cardiovasc Diabetol. 2018;17:127.","journal-title":"Cardiovasc Diabetol."},{"key":"304_CR76","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1159\/000494449","volume":"43","author":"J He","year":"2018","unstructured":"He J, Lu Y-P, Li J, Li T-Y, Chen X, Liang X-J, et al. Fetal but not maternal angiotensin converting enzyme (ACE)-2 gene Rs2074192 polymorphism is associated with increased risk of being a small for gestational age (SGA) newborn. Kidney Blood Press Res. 2018;43:1596\u2013606.","journal-title":"Kidney Blood Press Res."},{"key":"304_CR77","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.06.001","volume":"27","author":"X Wu","year":"2018","unstructured":"Wu X, Zhu B, Zou S, Shi J. The association between ACE2 gene polymorphism and the stroke recurrence in Chinese population. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc. 2018;27:2770\u201380.","journal-title":"J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc"},{"key":"304_CR78","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11010-017-3123-9","volume":"438","author":"A Kumar","year":"2018","unstructured":"Kumar A, Rani B, Sharma R, Kaur G, Prasad R, Bahl A, et al. ACE2, CALM3 and TNNI3K polymorphisms as potential disease modifiers in hypertrophic and dilated cardiomyopathies. Mol Cell Biochem. 2018;438:167\u201374.","journal-title":"Mol Cell Biochem."},{"key":"304_CR79","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12967-020-02486-7","volume":"18","author":"X Guo","year":"2020","unstructured":"Guo X, Chen Z, Xia Y, Lin W, Li H. Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2). J Transl Med. 2020;18:321. https:\/\/doi.org\/10.1186\/s12967-020-02486-7.","journal-title":"J Transl Med."},{"key":"304_CR80","doi-asserted-by":"publisher","first-page":"100979","DOI":"10.1016\/j.genrep.2020.100979","volume":"22","author":"A Paniri","year":"2021","unstructured":"Paniri A, Hosseini MM, Moballegh-Eslam M, Akhavan-Niaki H. Comprehensive in silico identification of impacts of ACE2 SNPs on COVID-19 susceptibility in different populations. Gene Rep. 2021;22:100979. https:\/\/doi.org\/10.1016\/j.genrep.2020.100979.","journal-title":"Gene Rep."},{"key":"304_CR81","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1016\/j.lfs.2005.09.038","volume":"78","author":"X Xudong","year":"2006","unstructured":"Xudong X, Junzhu C, Xingxiang W, Furong Z, Yanrong L. Age- and gender-related difference of ACE2 expression in rat lung. Life Sci. 2006;78:2166\u201371. https:\/\/doi.org\/10.1016\/j.lfs.2005.09.038.","journal-title":"Life Sci."},{"key":"304_CR82","doi-asserted-by":"publisher","first-page":"H10","DOI":"10.1152\/ajpheart.01277.2007","volume":"295","author":"KD Pendergrass","year":"2008","unstructured":"Pendergrass KD, Pirro NT, Westwood BM, Ferrario CM, Brosnihan KB, Chappell MC. Sex differences in circulating and renal angiotensins of hypertensive mRen(). Lewis but not normotensive Lewis rats. Am J Physiol Heart Circ Physiol. 2008;295:H10\u201320. https:\/\/doi.org\/10.1152\/ajpheart.01277.2007.","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"304_CR83","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/2042-6410-1-6","volume":"1","author":"J Liu","year":"2010","unstructured":"Liu J, Ji H, Zheng W, Wu X, Zhu JJ, Arnold AP, et al. Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17\u03b2-oestradiol-dependent and sex chromosome-independent. Biol Sex Differ. 2010;1:6. https:\/\/doi.org\/10.1186\/2042-6410-1-6.","journal-title":"Biol Sex Differ."},{"key":"304_CR84","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13168","volume":"19","author":"J Chen","year":"2020","unstructured":"Chen J, Jiang Q, Xia X, Liu K, Yu Z, Tao W, et al. Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation. Aging Cell. 2020;19:e13168. https:\/\/doi.org\/10.1111\/acel.13168.","journal-title":"Aging Cell"},{"key":"304_CR85","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nature24265","volume":"550","author":"T Tukiainen","year":"2017","unstructured":"Tukiainen T, Villani A-C, Yen A, Rivas MA, Marshall JL, Satija R, et al. Landscape of X chromosome inactivation across human tissues. Nature. 2017;550:244\u20138. https:\/\/doi.org\/10.1038\/nature24265.","journal-title":"Nature."},{"key":"304_CR86","doi-asserted-by":"publisher","first-page":"108410","DOI":"10.1016\/j.clim.2020.108410","volume":"215","author":"AH Sawalha","year":"2020","unstructured":"Sawalha AH, Zhao M, Coit P, Lu Q. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients. Clin Immunol Orlando Fla. 2020;215:108410. https:\/\/doi.org\/10.1016\/j.clim.2020.108410.","journal-title":"Clin Immunol Orlando Fla"},{"key":"304_CR87","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3892\/ijmm.2014.1692","volume":"33","author":"Y Yamada","year":"2014","unstructured":"Yamada Y, Nishida T, Horibe H, Oguri M, Kato K, Sawabe M. Identification of hypo- and hypermethylated genes related to atherosclerosis by a genome-wide analysis of DNA methylation. Int J Mol Med. 2014;33:1355\u201340. https:\/\/doi.org\/10.3892\/ijmm.2014.1692.","journal-title":"Int J Mol Med"},{"key":"304_CR88","doi-asserted-by":"publisher","unstructured":"Xue S, Liu D, Zhu W, Su Z, Zhang L, Zhou C, et al. Circulating MiR-17-5p, MiR-126-5p and MiR-145-3p are novel biomarkers for diagnosis of acute myocardial infarction. Front Physiol. 2019;10. https:\/\/doi.org\/10.3389\/fphys.2019.00123.","DOI":"10.3389\/fphys.2019.00123"},{"key":"304_CR89","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202003.0295.v1","volume-title":"DNA methylation analysis of the COVID-19 host cell receptor, angiotensin I converting enzyme 2 gene (ACE2) in the respiratory system reveal age and gender differences","author":"MJ Corley","year":"2020","unstructured":"Corley MJ, Ndhlovu LC. DNA methylation analysis of the COVID-19 host cell receptor, angiotensin I converting enzyme 2 gene (ACE2) in the respiratory system reveal age and gender differences; 2020. https:\/\/doi.org\/10.20944\/preprints202003.0295.v1."},{"key":"304_CR90","doi-asserted-by":"publisher","unstructured":"Pinto BGG, Oliveira AER, Singh Y, Jimenez L, Gon\u00e7alves ANA, Ogava RLT, et al. ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19. J Infect Dis. 2020. https:\/\/doi.org\/10.1093\/infdis\/jiaa332.","DOI":"10.1093\/infdis\/jiaa332"},{"key":"304_CR91","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.3892\/mmr.2017.6460","volume":"15","author":"R Fan","year":"2017","unstructured":"Fan R, Mao S-Q, Gu T-L, Zhong F-D, Gong M-L, Hao L-M, et al. Preliminary analysis of the association between methylation of the ACE2 promoter and essential hypertension. Mol Med Rep. 2017;15:3905\u201311. https:\/\/doi.org\/10.3892\/mmr.2017.6460.","journal-title":"Mol Med Rep."},{"key":"304_CR92","doi-asserted-by":"publisher","unstructured":"Steyaert S, Trooskens G, Delanghe JR, Criekinge WV. Differential methylation as a mediator of COVID-19 susceptibility. bioRxiv. 2020;2020.08.14.251538. https:\/\/doi.org\/10.1101\/2020.08.14.251538.","DOI":"10.1101\/2020.08.14.251538"},{"key":"304_CR93","doi-asserted-by":"publisher","unstructured":"Wicik Z, Eyileten C, Jakubik D, Sim\u00f5es SN, Martins DC, Pav\u00e3o R, et al. ACE2 interaction networks in COVID-19: a physiological framework for prediction of outcome in patients with cardiovascular risk factors. bioRxiv. 2020;2020.05.13.094714. https:\/\/doi.org\/10.1101\/2020.05.13.094714.","DOI":"10.1101\/2020.05.13.094714"},{"key":"304_CR94","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.yjmcc.2014.06.008","volume":"75","author":"JR Kemp","year":"2014","unstructured":"Kemp JR, Unal H, Desnoyer R, Yue H, Bhatnagar A, Karnik SS. Angiotensin II-regulated microRNA 483-3p directly targets multiple components of the renin-angiotensin system. J Mol Cell Cardiol. 2014;75:25\u201339. https:\/\/doi.org\/10.1016\/j.yjmcc.2014.06.008.","journal-title":"J Mol Cell Cardiol."},{"key":"304_CR95","first-page":"4055","volume":"20","author":"Y-F Huang","year":"2016","unstructured":"Huang Y-F, Zhang Y, Liu C-X, Huang J, Ding G-H. microRNA-125b contributes to high glucose-induced reactive oxygen species generation and apoptosis in HK-2 renal tubular epithelial cells by targeting angiotensin-converting enzyme 2. Eur Rev Med Pharmacol Sci. 2016;20:4055\u201362.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"304_CR96","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1042\/CS20130420","volume":"127","author":"DW Lambert","year":"2014","unstructured":"Lambert DW, Lambert LA, Clarke NE, Hooper NM, Porter KE, Turner AJ. Angiotensin-converting enzyme 2 is subject to post-transcriptional regulation by miR-421. Clin Sci Lond Engl. 2014;127:243\u20139.","journal-title":"Clin Sci Lond Engl"},{"key":"304_CR97","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1161\/HYPERTENSIONAHA.111.180729","volume":"58","author":"FZ Marques","year":"2011","unstructured":"Marques FZ, Campain AE, Maciej T, Ewa Z-S, Yang Yee Hwa J, Charchar Fadi J, et al. Gene expression profiling reveals renin mRNA overexpression in human hypertensive kidneys and a role for microRNAs. Hypertension. 2011;58:1093\u20138. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.180729.","journal-title":"Hypertension"},{"key":"304_CR98","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1159\/000430393","volume":"37","author":"H Bao","year":"2015","unstructured":"Bao H, Gao F, Xie G, Liu Z. Angiotensin-converting enzyme 2 inhibits apoptosis of pulmonary endothelial cells during acute lung injury through suppressing MiR-4262. Cell Physiol Biochem. 2015;37:759\u201367. https:\/\/doi.org\/10.1159\/000430393.","journal-title":"Cell Physiol Biochem."},{"key":"304_CR99","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1111\/jcmm.13471","volume":"22","author":"C Zhang","year":"2018","unstructured":"Zhang C, Wang J, Ma X, Wang W, Zhao B, Chen Y, et al. ACE2-EPC-EXs protect ageing ECs against hypoxia\/reoxygenation-induced injury through the miR-18a\/Nox2\/ROS pathway. J Cell Mol Med. 2018;22:1873\u201382. https:\/\/doi.org\/10.1111\/jcmm.13471.","journal-title":"J Cell Mol Med."},{"key":"304_CR100","doi-asserted-by":"publisher","unstructured":"Sun N-N, Yu C-H, Pan M-X, Zhang Y, Zheng B-J, Yang Q-J, et al. Mir-21 Mediates the inhibitory effect of Ang (1\u20137) on AngII-induced NLRP3 inflammasome activation by targeting Spry1 in lung fibroblasts. Sci Rep. 2017;7. https:\/\/doi.org\/10.1038\/s41598-017-13305-3.","DOI":"10.1038\/s41598-017-13305-3"},{"key":"304_CR101","doi-asserted-by":"publisher","unstructured":"Liu Y, Afzal J, Vakrou S, Greenland GV, Talbot CC, Hebl VB, et al. Differences in microRNA-29 and pro-fibrotic gene expression in mouse and human hypertrophic cardiomyopathy. Front Cardiovasc Med. 2019;6. https:\/\/doi.org\/10.3389\/fcvm.2019.00170.","DOI":"10.3389\/fcvm.2019.00170"},{"key":"304_CR102","doi-asserted-by":"publisher","unstructured":"Mallick B, Ghosh Z, Chakrabarti J. MicroRNome analysis unravels the molecular basis of SARS infection in bronchoalveolar stem cells. PLoS ONE. 2009;4. https:\/\/doi.org\/10.1371\/journal.pone.0007837.","DOI":"10.1371\/journal.pone.0007837"},{"key":"304_CR103","doi-asserted-by":"publisher","unstructured":"B T, T I, C U, R F, M G. Circulating miR-421 targeting leucocytic angiotensin converting enzyme 2 is elevated in patients with chronic kidney disease. Nephron. 2019;141. https:\/\/doi.org\/10.1159\/000493805.","DOI":"10.1159\/000493805"},{"key":"304_CR104","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.15537\/smj.2015.10.12458","volume":"36","author":"H-B Wang","year":"2015","unstructured":"Wang H-B, Yang J. The role of renin-angiotensin aldosterone system related micro-ribonucleic acids in hypertension. Saudi Med J. 2015;36:1151\u20135. https:\/\/doi.org\/10.15537\/smj.2015.10.12458.","journal-title":"Saudi Med J"},{"key":"304_CR105","doi-asserted-by":"publisher","unstructured":"Pierce JB, Simion V, Icli B, P\u00e9rez-Cremades D, Cheng HS, Feinberg MW. Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs. Genes (Basel). 2020;11(11):1354. https:\/\/doi.org\/10.3390\/genes11111354.","DOI":"10.3390\/genes11111354"},{"key":"304_CR106","doi-asserted-by":"publisher","first-page":"L1280","DOI":"10.1152\/ajplung.00153.2020","volume":"318","author":"KE Stelzig","year":"2020","unstructured":"Stelzig KE, Canepa-Escaro F, Schiliro M, Berdnikovs S, Prakash YS, Chiarella SE. Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells. Am J Physiol - Lung Cell Mol Physiol. 2020;318:L1280\u20131. https:\/\/doi.org\/10.1152\/ajplung.00153.2020.","journal-title":"Am J Physiol - Lung Cell Mol Physiol."},{"key":"304_CR107","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1177\/1535370217718808","volume":"242","author":"A Bukowska","year":"2017","unstructured":"Bukowska A, Spiller L, Wolke C, Lendeckel U, Weinert S, Hoffmann J, et al. Protective regulation of the ACE2\/ACE gene expression by estrogen in human atrial tissue from elderly men. Exp Biol Med Maywood NJ. 2017;242:1412\u201323.","journal-title":"Exp Biol Med Maywood NJ"},{"key":"304_CR108","doi-asserted-by":"publisher","unstructured":"Kalidhindi RSR, Borkar NA, Ambhore NS, Pabelick CM, Prakash Y, Sathish V. Sex steroids skew ACE2 expression in human airway: a contributing factor to sex differences in COVID-19? Am J Physiol-Lung Cell Mol Physiol. 2020. https:\/\/doi.org\/10.1152\/ajplung.00391.2020.","DOI":"10.1152\/ajplung.00391.2020"},{"key":"304_CR109","doi-asserted-by":"publisher","unstructured":"Patanavanich R, Glantz SA. Smoking is associated with COVID-19 progression: a meta-analysis. Nicotine Tob Res. 2020. https:\/\/doi.org\/10.1093\/ntr\/ntaa082.","DOI":"10.1093\/ntr\/ntaa082"},{"key":"304_CR110","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.devcel.2020.05.012","volume":"53","author":"JC Smith","year":"2020","unstructured":"Smith JC, Sausville EL, Girish V, Yuan ML, Vasudevan A, John KM, et al. cigarette smoke exposure and inflammatory signaling increase the expression of the SARS-CoV-2 receptor ACE2 in the respiratory tract. Dev Cell. 2020;53:514\u2013529.e3. https:\/\/doi.org\/10.1016\/j.devcel.2020.05.012.","journal-title":"Dev Cell"},{"key":"304_CR111","doi-asserted-by":"publisher","unstructured":"Thul PJ, \u00c5kesson L, Wiking M, Mahdessian D, Geladaki A, Blal HA, et al. A subcellular map of the human proteome. Science. 2017;356. https:\/\/doi.org\/10.1126\/science.aal3321.","DOI":"10.1126\/science.aal3321"},{"key":"304_CR112","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1242\/dmm.014589","volume":"7","author":"SP Ferris","year":"2014","unstructured":"Ferris SP, Kodali VK, Kaufman RJ. Glycoprotein folding and quality-control mechanisms in protein-folding diseases. Dis Model Mech. 2014;7:331. https:\/\/doi.org\/10.1242\/dmm.014589.","journal-title":"Dis Model Mech."},{"key":"304_CR113","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1083\/jcb.201312042","volume":"204","author":"A Ruggiano","year":"2014","unstructured":"Ruggiano A, Foresti O, Carvalho P. Quality control: ER-associated degradation: protein quality control and beyond. J Cell Biol. 2014;204:869. https:\/\/doi.org\/10.1083\/jcb.201312042.","journal-title":"J Cell Biol."},{"key":"304_CR114","volume-title":"The Golgi Apparatus. Landes Bioscience","author":"Z Hua","year":"2013","unstructured":"Hua Z, Graham TR. The Golgi Apparatus. Landes Bioscience; 2013. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK6268\/. Accessed 14 Oct 2020."},{"key":"304_CR115","doi-asserted-by":"publisher","first-page":"127115","DOI":"10.1016\/j.bmcl.2020.127115","volume":"30","author":"LA Lumangtad","year":"2020","unstructured":"Lumangtad LA, Bell TW. The signal peptide as a new target for drug design. Bioorg Med Chem Lett. 2020;30:127115. https:\/\/doi.org\/10.1016\/j.bmcl.2020.127115.","journal-title":"Bioorg Med Chem Lett."},{"key":"304_CR116","unstructured":"Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Transport from the ER through the Golgi Apparatus. Mol Biol Cell 4th Ed. 2002; https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK26941\/. Accessed 14 Oct 2020."},{"key":"304_CR117","doi-asserted-by":"publisher","unstructured":"Ogunlade B, Guidry JJ, Mukerjee S, Sriramula S, Lazartigues E, Filipeanu CM. The actin bundling protein Fascin-1 as an ACE2-accessory protein. Cell Mol Neurobiol. 2020. https:\/\/doi.org\/10.1007\/s10571-020-00951-x.","DOI":"10.1007\/s10571-020-00951-x"},{"key":"304_CR118","doi-asserted-by":"publisher","unstructured":"Sun Z, Ren K, Zhang X, Chen J, Jiang Z, Jiang J, et al. Mass spectrometry analysis of newly emerging coronavirus HCoV-19 spike protein and human ACE2 reveals camouflaging glycans and unique post-translational modifications. Eng Beijing China. 2020. https:\/\/doi.org\/10.1016\/j.eng.2020.07.014.","DOI":"10.1016\/j.eng.2020.07.014"},{"key":"304_CR119","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1038\/sj.emboj.7600640","volume":"24","author":"W Li","year":"2005","unstructured":"Li W, Zhang C, Sui J, Kuhn JH, Moore MJ, Luo S, et al. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J. 2005;24:1634\u201343. https:\/\/doi.org\/10.1038\/sj.emboj.7600640.","journal-title":"EMBO J."},{"key":"304_CR120","doi-asserted-by":"publisher","unstructured":"Mehdipour AR, Hummer G. Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike. bioRxiv. 2020;:2020.07.09.193680. https:\/\/doi.org\/10.1101\/2020.07.09.193680.","DOI":"10.1101\/2020.07.09.193680"},{"key":"304_CR121","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1128\/AAC.03999-14","volume":"59","author":"X Zhao","year":"2015","unstructured":"Zhao X, Guo F, Comunale MA, Mehta A, Sehgal M, Jain P, et al. Inhibition of endoplasmic reticulum-resident glucosidases impairs severe acute respiratory syndrome coronavirus and human coronavirus NL63 spike protein-mediated entry by altering the glycan processing of angiotensin i-converting enzyme 2. Antimicrob Agents Chemother. 2015;59:206\u201316. https:\/\/doi.org\/10.1128\/AAC.03999-14.","journal-title":"Antimicrob Agents Chemother"},{"key":"304_CR122","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1743-422X-2-69","volume":"2","author":"MJ Vincent","year":"2005","unstructured":"Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, Ksiazek TG, et al. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. 2005;2:69. https:\/\/doi.org\/10.1186\/1743-422X-2-69.","journal-title":"Virol J"},{"key":"304_CR123","doi-asserted-by":"publisher","unstructured":"Lichtenthaler SF, Lemberg MK, Fluhrer R. Proteolytic ectodomain shedding of membrane proteins in mammals\u2014hardware, concepts, and recent developments. EMBO J. 2018;37. https:\/\/doi.org\/10.15252\/embj.201899456.","DOI":"10.15252\/embj.201899456"},{"key":"304_CR124","doi-asserted-by":"publisher","first-page":"30113","DOI":"10.1074\/jbc.M505111200","volume":"280","author":"DW Lambert","year":"2005","unstructured":"Lambert DW, Yarski M, Warner FJ, Thornhill P, Parkin ET, Smith AI, et al. Tumor necrosis factor-\u03b1 convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J Biol Chem. 2005;280:30113\u20139. https:\/\/doi.org\/10.1074\/jbc.M505111200.","journal-title":"J Biol Chem."},{"key":"304_CR125","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1161\/HYPERTENSIONAHA.108.124339","volume":"53","author":"HA Shaltout","year":"2009","unstructured":"Shaltout HA, Figueroa JP, Rose JC, Diz DI, Chappell MC. Alterations in circulatory and renal angiotensin-converting enzyme and angiotensin-converting enzyme 2 in fetal programmed hypertension. Hypertension. 2009;53:404\u20138. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.108.124339.","journal-title":"Hypertension."},{"key":"304_CR126","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1128\/JVI.02202-13","volume":"88","author":"A Heurich","year":"2014","unstructured":"Heurich A, Hofmann-Winkler H, Gierer S, Liepold T, Jahn O, P\u00f6hlmann S. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol. 2014;88:1293\u2013307. https:\/\/doi.org\/10.1128\/JVI.02202-13.","journal-title":"J Virol"},{"key":"304_CR127","doi-asserted-by":"publisher","first-page":"12658","DOI":"10.1128\/JVI.01542-10","volume":"84","author":"S Matsuyama","year":"2010","unstructured":"Matsuyama S, Nagata N, Shirato K, Kawase M, Takeda M, Taguchi F. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J Virol. 2010;84:12658\u201364.","journal-title":"J Virol."},{"key":"304_CR128","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1128\/JVI.02062-10","volume":"85","author":"A Shulla","year":"2011","unstructured":"Shulla A, Heald-Sargent T, Subramanya G, Zhao J, Perlman S, Gallagher T. A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. J Virol. 2011;85:873\u201382.","journal-title":"J Virol"},{"key":"304_CR129","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1161\/HYPERTENSIONAHA.114.03743","volume":"64","author":"MR Deshotels","year":"2014","unstructured":"Deshotels MR, Huijing X, Srinivas S, Eric L, Filipeanu Catalin M. Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin ii type i receptor\u2013dependent mechanism. Hypertension. 2014;64:1368\u201375. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.03743.","journal-title":"Hypertension"},{"key":"304_CR130","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/cr.2008.15","volume":"18","author":"H Wang","year":"2008","unstructured":"Wang H, Yang P, Liu K, Guo F, Zhang Y, Zhang G, et al. SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway. Cell Res. 2008;18:290\u2013301. https:\/\/doi.org\/10.1038\/cr.2008.15.","journal-title":"Cell Res."},{"key":"304_CR131","doi-asserted-by":"publisher","unstructured":"Bayati A, Kumar R, Francis V, McPherson PS. SARS-CoV-2 uses clathrin-mediated endocytosis to gain access into cells. bioRxiv. 2020;:2020.07.13.201509. https:\/\/doi.org\/10.1101\/2020.07.13.201509.","DOI":"10.1101\/2020.07.13.201509"},{"key":"304_CR132","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.110.955369","volume":"122","author":"J Zhong","year":"2010","unstructured":"Zhong J, Basu R, Guo D, Chow FL, Byrns S, Schuster M, et al. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction. Circulation. 2010;122:717\u201328 18 p following 728.","journal-title":"Circulation"},{"key":"304_CR133","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1139\/cjpp-2013-0488","volume":"92","author":"N Parajuli","year":"2014","unstructured":"Parajuli N, Ramprasath T, Patel VB, Wang W, Putko B, Mori J, et al. Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases. Can J Physiol Pharmacol. 2014;92:558\u201365.","journal-title":"Can J Physiol Pharmacol."},{"key":"304_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30116-8","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8:e21. https:\/\/doi.org\/10.1016\/S2213-2600(20)30116-8.","journal-title":"Lancet Respir Med."},{"key":"304_CR135","doi-asserted-by":"publisher","first-page":"E004","DOI":"10.3760\/cma.j.cn112148-20200220-00105","volume":"48","author":"P Yudong","year":"2020","unstructured":"Yudong P, Kai M, Hongquan G, Liang L, Ruirui Z, Boyuan W, et al. Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV. Chin J Cardiol. 2020;48:E004. https:\/\/doi.org\/10.3760\/cma.j.cn112148-20200220-00105.","journal-title":"Chin J Cardiol"},{"key":"304_CR136","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1136\/heartjnl-2020-317393","volume":"106","author":"J Hippisley-Cox","year":"2020","unstructured":"Hippisley-Cox J, Young D, Coupland C, Channon KM, Tan PS, Harrison DA, et al. Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people. Heart. 2020;106:1503\u201311. https:\/\/doi.org\/10.1136\/heartjnl-2020-317393.","journal-title":"Heart."},{"key":"304_CR137","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","volume":"76","author":"P Verdecchia","year":"2020","unstructured":"Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med. 2020;76:14\u201320. https:\/\/doi.org\/10.1016\/j.ejim.2020.04.037.","journal-title":"Eur J Intern Med."},{"key":"304_CR138","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","volume":"181","author":"V Monteil","year":"2020","unstructured":"Monteil V, Kwon H, Prado P, Hagelkr\u00fcys A, Wimmer RA, Stahl M, et al. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell. 2020;181:905\u2013913.e7. https:\/\/doi.org\/10.1016\/j.cell.2020.04.004.","journal-title":"Cell"},{"key":"304_CR139","doi-asserted-by":"publisher","unstructured":"Lutz C, Maher L, Lee C, Kang W. COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice. Hum Genomics. 2020;14. https:\/\/doi.org\/10.1186\/s40246-020-00272-6.","DOI":"10.1186\/s40246-020-00272-6"},{"key":"304_CR140","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1038\/s41596-020-00403-2","volume":"15","author":"CB Gurumurthy","year":"2020","unstructured":"Gurumurthy CB, Quadros RM, Richardson GP, Poluektova LY, Mansour SL, Ohtsuka M. Genetically modified mouse models to help fight COVID-19. Nat Protoc. 2020;15:3777\u201387. https:\/\/doi.org\/10.1038\/s41596-020-00403-2.","journal-title":"Nat Protoc."},{"key":"304_CR141","doi-asserted-by":"publisher","unstructured":"Aydemir D, Ulusu NN. Correspondence: angiotensin-converting enzyme 2 coated nanoparticles containing respiratory masks, chewing gums and nasal filters may be used for protection against COVID-19 infection. Travel Med Infect Dis. 2020. https:\/\/doi.org\/10.1016\/j.tmaid.2020.101697.","DOI":"10.1016\/j.tmaid.2020.101697"},{"key":"304_CR142","doi-asserted-by":"publisher","unstructured":"de Oliveira RM, Marijanovic Z, Carvalho F, Milt\u00e9nyi GM, Matos JE, Tenreiro S, et al. Impaired proteostasis contributes to renal tubular dysgenesis. PLoS ONE. 2011;6. https:\/\/doi.org\/10.1371\/journal.pone.0020854.","DOI":"10.1371\/journal.pone.0020854"},{"key":"304_CR143","doi-asserted-by":"publisher","first-page":"23253","DOI":"10.1074\/jbc.M000593200","volume":"275","author":"KR Santhamma","year":"2000","unstructured":"Santhamma KR, Sen I. Specific cellular proteins associate with angiotensin-converting enzyme and regulate its intracellular transport and cleavage-secretion. J Biol Chem. 2000;275:23253\u20138.","journal-title":"J Biol Chem."},{"key":"304_CR144","doi-asserted-by":"publisher","unstructured":"Danilov SM, Kalinin S, Chen Z, Vinokour EI, Nesterovitch AB, Schwartz DE, et al. Angiotensin I-converting enzyme Gln1069Arg mutation impairs trafficking to the cell surface resulting in selective denaturation of the C-domain. PLoS ONE. 2010;5. https:\/\/doi.org\/10.1371\/journal.pone.0010438.","DOI":"10.1371\/journal.pone.0010438"},{"key":"304_CR145","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/hmg\/ddt535","volume":"23","author":"A Michaud","year":"2014","unstructured":"Michaud A, Acharya KR, Masuyer G, Quenech\u2019du N, Gribouval O, Morini\u00e8re V, et al. Absence of cell surface expression of human ACE leads to perinatal death. Hum Mol Genet. 2014;23:1479\u201391. https:\/\/doi.org\/10.1093\/hmg\/ddt535.","journal-title":"Hum Mol Genet"},{"key":"304_CR146","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1126\/science.abc0870","volume":"369","author":"KK Chan","year":"2020","unstructured":"Chan KK, Dorosky D, Sharma P, Abbasi SA, Dye JM, Kranz DM, et al. Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2. Science. 2020;369:1261\u20135.","journal-title":"Science."}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-021-00304-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40246-021-00304-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-021-00304-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T04:52:41Z","timestamp":1611895961000},"score":1,"resource":{"primary":{"URL":"https:\/\/humgenomics.biomedcentral.com\/articles\/10.1186\/s40246-021-00304-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":146,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["304"],"URL":"https:\/\/doi.org\/10.1186\/s40246-021-00304-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints202011.0673.v1","asserted-by":"object"}]},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,29]]},"assertion":[{"value":"10 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}